APELLIS PHARMACEUTICALS INC - NOTE 3.500% 9/1

Historical Portfolio Holders from Q3 2020 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Debt / NOTE 3.500% 9/1
Principal, excl. options Q1 2024
66.1 M
Holdings value Q1 2024
$108 M
Value change Q1 2024
+$20.9 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
12
Number of buys Q1 2024
6
Number of sells Q1 2024
-5
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
03753UAB2
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q1 $66.1 M $108 M +$20.9 M $1.63 12
2023 Q4 $53.3 M $108 M +$8.51 M $1.63 10
2023 Q3 $48.3 M $76.4 M -$48.9 M $1.26 10
2023 Q2 $71.9 M $184 M -$13.9 M $2.40 13
2023 Q1 $94.2 M $175 M +$774 K $1.86 9
2022 Q4 $93.8 M $144 M -$5.75 M $1.54 11
2022 Q3 $92.6 M $179 M -$79.4 M $1.95 11
2022 Q2 $139 M $206 M -$92.8 M $1.49 12
2022 Q1 $200 M $315 M +$5.81 M $1.58 16
2021 Q4 $198 M $299 M +$5.67 M $1.51 22
2021 Q3 $197 M $242 M -$336 M $1.23 22
2021 Q2 $401 M $746 M +$577 M $1.86 37
2021 Q1 $96.6 M $136 M -$99.9 M $1.40 20
2020 Q4 $211 M $222 M -$60.4 M $1.68 28
2020 Q3 $215 M $209 M +$209 M $1.07 26